TRAVERE THERAPEUTICS, INC. (TVTX)

SEC filing

TRAVERE THERAPEUTICS, INC.

TVTX · CIK 1438533

4 · Sep 17, 2026 · SVP, CHIEF ACCOUNTING OFFICER Calvin Sandra sold 5,375 shares at $62.33/share ($335.0K); exercised options for 10.75K shares

SVP, CHIEF ACCOUNTING OFFICER Calvin Sandra sold 5,375 shares at $62.33/share ($335.0K); exercised options for 10.75K shares

xslF345X06/form4-09182026_010916.xml

xslF345X06/form4-09182026_010916.xmlSEC.gov

Graphics and non-inline formats (not embedded below).